Synaptic density, tau and multiparametric PET-MR for quantitative functional assessment and prognosis in mild cognitive and behavioural impairment KU Leuven
With annually 9.9 million new cases worldwide and as one of the
costliest diseases, the impact of dementia cannot be underestimated.
Although research in this domain has made significant progress,
major challenges still lie ahead. There is a growing need of
biomarkers with the capacity to diagnose Alzheimer’s disease (AD) in
an early stage, predict prognosis for prodromal patients and monitor
...